ARticles & Awards

Newsroom

press releases

media coverage

awards

Stay informed with the latest updates and developments from Prevencio by visiting our newsroom. Discover our featured press and read about the company's current happenings.

Media, please reach out to us at HART@prevenciomed.com for any press inquiries.

Awards

Media Coverage

READ ARTICLE >

Early Mass General Study Results Could Broaden Use Case for Prevencio Heart Disease Test

360 dx

november 17, 2023

READ ARTICLE >

Massachusetts General Hospital Researchers and Prevencio Announce AI-driven HART® CVE Blood Test Accuracy for Patients with Coronary Chronic Total Occlusion

business wire

october 24, 2023

READ ARTICLE >

Prevencio Announces National Medicare Pricing for Company’s Three AI-Powered HART® Cardiac Blood Tests. Newly Assigned Rates Further Validate Commercial Value of the HART Tests

Biospace

January 10, 2023

READ ARTICLE >

Prevencio's AI blood test predicts cardiovascular risk one year out for people with diabetes 

FIERCE BIOTECH

april 13, 2022

READ ARTICLE >

Prevencio Progresses on Commercialization Plans After Receiving CPT PLA Codes

360 dx

March 16, 2022

READ ARTICLE >

Prevencio’s Novel AI-Driven HART CADhs Blood Test Significantly More Accurate than Troponin for Obstructive Heart Disease

biospace

september 1, 2021

READ ARTICLE >

Prevencio links with Atlas Genomics to roll out AI-powered blood tests for heart disease

fierce biotech

april 22, 2021

READ ARTICLE >

Top 10 Atherosclerosis startups

medical startups

December 13, 2022

READ ARTICLE >

Top 10 Heart Disease Startups

medical startups

December 10, 2022

READ ARTICLE >

Scientists Developing Diagnostic Test for Childhood Disease Linked to Covid-19

wall street journal

may 29, 2020

READ ARTICLE >

The Hunt to Understand COVID-19's Connection to Kawasaki Disease

time

may 27, 2020

READ ARTICLE >

Prevencio and Seattle Children’s Research Institute Ink Agreement for Kawasaki Disease Diagnostic Test

biospace

may 12, 2020

READ ARTICLE >

Bayer G4A partners with Seattle startups Litesprite and Prevencio on digital health efforts

geekwire

october 17, 2019

READ ARTICLE >

Bayer to back 11 international startups in various digital health enterprises

fierce biotech

october 14, 2019

READ ARTICLE >

Eleven startups join Bayer’s G4A Digital Health Partnerships programme

mobile health news

october 14, 2019

READ ARTICLE >

Biotech Veteran Rhonda Rhyne Guides Growing & Innovative Cardio- Diagnostic Company

mike flynn & Associates

March 15, 2019

READ ARTICLE >

Q&A: Health tech for diagnosing peripheral artery disease 

digital journal

september 2, 2018

READ ARTICLE >

Clinical, biomarker score predicts PAD

healio

august 1, 2018

READ ARTICLE >

Study: Prevencio blood test accurately predicts the presence of obstructive CAD

fierce biotech

february 28, 2017

READ ARTICLE >

Scoring system helps diagnose patients with obstructive CAD

healio

february 28, 2017

READ ARTICLE >

Study: Seattle-area startup’s test diagnoses heart disease more effectively than current methods

geekwire

february 27, 2017

Press Releases

READ ARTICLE >

Prevencio Granted U.S. Patent for Highly Accurate, Artificial Intelligence-driven Blood Test for Obstructive Coronary Artery Disease

business wire

july 24, 2024

READ ARTICLE >

Prevencio Selected for Prestigious MedTech Innovator 2024 Accelerator Cohort

business wire

june 5, 2024

READ ARTICLE >

Prevencio Announces Laboratory Commercialization Partnership with Complete Omics Incorporating Microsoft’s AI-computing Cloud

april 2, 2024

READ ARTICLE >

Prevencio and Emory Winship Cancer Institute AI-driven HART CVE Test Data Predicts Risk of Adverse Cardiovascular Effects Associated with Prostate Cancer Therapy

business wire

february 7, 2024

READ ARTICLE >

Early Mass General Study Results Could Broaden Use Case for Prevencio Heart Disease Test

360 dx

november 17, 2023

READ ARTICLE >

Massachusetts General Hospital Researchers and Prevencio Announce AI-driven HART® CVE Blood Test Accuracy for Patients with Coronary Chronic Total Occlusion

business wire

october 24, 2023

Massachusetts General Hospital Researchers and Prevencio Announce the Power of Artificial Intelligence HART® Platform for Medical Diagnostic Test Development

business wire

July 24, 2023

READ ARTICLE >

Prevencio Announces National Medicare Pricing for Company’s Three AI-Powered HART® Cardiac Blood Tests.  Newly Assigned Rates Further Validate Commercial Value of the HART Tests

business wire

January 10, 2023

READ ARTICLE >

Massachusetts’s General Hospital Study Demonstrates Prevencio’s AI-driven HART CVE Blood Test Highly Accurate for Predicting Major Cardiac Events in Patients with Chronic Kidney Disease

business wire

November 3, 2022

READ ARTICLE >

Prevencio Announces Agreement with Alivio Health Expanding Access to AI-driven Cardiac HART Tests Offered by Atlas Genomics

business wire

July 19, 2022

READ ARTICLE >

Massachusetts’s General Hospital Study Demonstrates Prevencio’s AI-driven HART CVE Blood Test Highly Accurate in Patients with Diabetes for Predicting Heart Attack, Stroke, and Cardiac Death Risk

business wire

April 12, 2022

READ ARTICLE >

American Medical Association (AMA) Grants Prevencio Three CPT® PLA Reimbursement Codes for Novel AI-driven Cardiac HART® Blood Tests

business wire

January 11, 2022

READ ARTICLE >

Prevencio’s AI-driven HART CADhs Blood Test Significantly More Accurate than Troponin for Heart Disease Diagnosis in Diabetic Patients

business wire

November 16, 2021

READ ARTICLE >

Prevencio and Seattle Children’s Research Institute Present Highly Accurate, AI-driven HART KD Data on First Blood Test for Kawasaki Disease at Premiere International Kawasaki Disease Scientific Sessions 

business wire

November 9, 2021

READ ARTICLE >

Prevencio and Memorial Sloan Kettering Cancer Center Data Demonstrates Significant Correlation of AI-driven HART CVE Blood Test Scores with Development of Adverse Heart Events Following Cancer Radiation Treatment

business wire

October 27, 2021

READ ARTICLE >

Prevencio’s AI-driven HART CVE Blood Test Demonstrates Usefulness in Spinal Cord Injury Patients

business wire

October 4, 2021

READ ARTICLE >

Prevencio’s Novel AI-driven HART CADhs Blood Test
Significantly More Accurate than Troponin for Obstructive Heart Disease

business wire

September 1, 2021

READ ARTICLE >

Prevencio Announces U.S. Patent Issuance for Novel,
Artificial Intelligence-driven Blood Test for Cardiac Risk

business wire

august 4, 2021

READ ARTICLE >

Multinational Patient Study Demonstrates Prevencio’s AI-driven HART Blood Test Highly Accurate for Risk of Heart Attack, Stroke, and Cardiac Death

business wire

may 18, 2021

READ ARTICLE >

Prevencio and Seattle Children’s Research Institute Present Highly Accurate Data for First Time Artificial Intelligence-driven
Multiple Protein Blood Test for Kawasaki Disease

business wire

May 4, 2021

READ ARTICLE >

Prevencio Announces Laboratory Commercialization Partnership with Atlas Genomics Incorporating Microsoft’s AI-computing Cloud

business wire

april 21, 2021

READ ARTICLE >

Prevencio Develops Highly Accurate, Artificial Intelligence-driven Blood Test for Kawasaki Disease

business wire

September 17, 2020

READ ARTICLE >

Prevencio and Seattle Children’s Research Institute Ink Agreement for Kawasaki Disease Diagnostic Test

business wire

May 12, 2020

READ ARTICLE >

Prevencio Inks Microsoft Deal

business wire

March 10, 2020

READ ARTICLE >

Prevencio Announces Highly Accurate, AI-driven Blood Test with High Sensitivity (hs) Cardiac Troponin for the Diagnosis of Heart Disease

business wire

November 19, 2019

READ ARTICLE >

Bayer inks deals with eleven startups, including Prevencio, under Bayer’s G4A Digital Health Partnerships

business wire

October 10, 2019

READ ARTICLE >

Prevencio Announces Two Validation Studies Confirming High Accuracy of Novel HART AI-driven Tests

business wire

march 18, 2019

READ ARTICLE >

Prevencio Announces Two Additional Peer-reviewed Manuscripts for Novel HART Tests using AI-driven Approach

business wire

January 28, 2019

READ ARTICLE >

New Prevencio Study Using AI Demonstrates Novel Blood Test Accurately Predicts Acute Kidney Injury (AKI) Risk

business wire

November 12, 2018

READ ARTICLE >

Prevencio Announces Data Demonstrating HART PAD Blood Test Accurately Diagnoses Peripheral Artery Disease in Diabetic Patients

pr newswire

August 27, 2018

READ ARTICLE >

Clinical Cardiology Publishes Study Demonstrating Simple Blood Test from Prevencio Accurately Detects Cardiovascular Disease

business wire

July 25, 2018

READ ARTICLE >

New Prevencio Study Using AI Determines Simple Blood Tests Accurately Diagnose Heart Disease and Predict Adverse Heart Events in Diabetic Patients

business wire

june 25, 2018

READ ARTICLE >

New Prevencio Study Using AI Demonstrates Simple Blood Test Accurately Diagnoses Aortic Stenosis

business wire

March 07, 2018

READ ARTICLE >

New Study Using Artificial Intelligence Shows Prevencio’s Simple Blood Test Accurately Detects Presence of Peripheral Artery Disease

business wire

November 14, 2017

READ ARTICLE >

New Blood Test Predicts Major Cardiac Events Better Than Clinical Evaluation of Other Common Risk Factors

business wire

April 26, 2017

READ ARTICLE >

New Study Shows Prevencio’s Simple Blood Test Determines Risk of Heart Attack, Stroke, or Cardiovascular Death

business wire

March 17, 2017

READ ARTICLE >

Prevencio, Inc. data published in Journal of the American College of Cardiology (JACC) shows new blood test predicts significant heart disease 90 percent of the time, also predicts risk of future heart attack

business wire

February 27, 2017

READ ARTICLE >

Prevencio Researchers Identify Clinical and Multi-Protein Test Panel to Diagnose Obstructive Coronary Artery Disease

pr newswire

September 07, 2016

READ ARTICLE >

Our Tests

Healthcare Professionals

Patients

About

Press

Blog

Contact

Order Test Kit